Aryl-Cyclohexanone as a Potential CB2 Agonist: In Vitro and In Silico Evidence in Inflammatory Modulation.
| Journal | Immunopharmacology and immunotoxicology |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
Inflammation is an evolutionarily conserved adaptive process essential for host defense against harmful stimuli, aimed at restoring homeostasis. However, exacerbated or dysregulated responses are associated with the progression of several autoimmune and chronic inflammatory diseases, representing a significant clinical challenge. The endocannabinoid system has been described as an important immunomodulatory pathway in which synthetic cannabinoids exert immunosuppressive effects, providing novel therapeutic targets. Aryl-Cyclohexanone (AD) has previously demonstrated anti-inflammatory properties in both Herein we aimed to investigate its immunomodulatory profile In J774 macrophages, AD treatment preserved cell viability, reduced nitric oxide metabolites production, normalized apoptotic events, and enhanced phagocytosis. Additionally, decreased Toll-like receptor 4 and increased mannose receptor (CD206) expressions were observed, along with a significant reduction in pro-inflammatory cyt
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Why is dysregulated inflammation an important target for new treatments?
Inflammation is an evolutionarily conserved process essential for host defense against harmful stimuli and for restoring homeostasis. However, exacerbated or dysregulated inflammatory responses are associated with the progression of several autoimmune and chronic inflammatory diseases, which represents a significant clinical challenge.
How is the endocannabinoid system connected to inflammation?
The endocannabinoid system has been described as an important immunomodulatory pathway, meaning it helps regulate immune responses. Within this pathway, synthetic cannabinoids exert immunosuppressive effects, which is why it is seen as a source of novel therapeutic targets for inflammatory conditions.
What is aryl-cyclohexanone, and why was it studied?
Aryl-cyclohexanone, abbreviated AD, is a compound that had previously demonstrated anti-inflammatory properties. Building on that earlier work, the researchers aimed to investigate its immunomodulatory profile by testing its effects on J774 macrophages.
What effects did aryl-cyclohexanone have on macrophages?
In J774 macrophages, treatment with aryl-cyclohexanone preserved cell viability, reduced production of nitric oxide metabolites, normalized apoptotic events and enhanced phagocytosis. The researchers also observed decreased Toll-like receptor 4 expression and increased mannose receptor (CD206) expression. The summary does not describe any testing in patients.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
